J&J recalls Procrit lot with cracked vials
This article was originally published in Scrip
Executive Summary
Johnson & Johnson's Ortho Biotech division has recalled one manufacturing lot of its erythropoiesis-stimulating agent Procrit (epoetin-alfa) in the US owing to cracks in the necks of some vials. More than 44,000 vials in the affected lot were distributed between April 15th and July 17th. The company said it had not received any reports of adverse events or complaints, but cracked vials may lose their sterility and should not be used for subcutaneous or intravenous injection. The amount of Procrit being withdrawn represents a very small proportion of the total product in the distribution channel and J&J does not anticipate a supply disruption.